← 治験一覧に戻る
希少がんにおけるマーカー支援選択的治療:知識データベース構築レジストリアジア
基本情報
- NCT ID
- NCT05217407
- ステータス
- 募集中
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 1,000
- 治験依頼者名
- National Cancer Center, Japan
概要
This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing. The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
対象疾患
Rare Malignant Neoplasm
介入
Genomic sequence(OTHER)
依頼者(Sponsor)
National Cancer Center, Japan(OTHER_GOV)
実施施設 (1)
国立研究開発法人国立がん研究センター中央病院
Chuo-ku, Tokyo, Japan(RECRUITING)